CD44 and breast carcinoma: Recently, using the mammosphere model combined with DNA methylation bead arrays and quantitative gene expression analysis, Hernandez-Vargas et al. demonstrated a constitutive activation of the JAK-STAT pathway in CD44+CD24-/low breast cancer stem cells[34].